11 research outputs found

    Affine extension of noncrystallographic Coxeter groups and quasicrystals

    Full text link
    Unique affine extensions H^{\aff}_2, H^{\aff}_3 and H^{\aff}_4 are determined for the noncrystallographic Coxeter groups H2H_2, H3H_3 and H4H_4. They are used for the construction of new mathematical models for quasicrystal fragments with 10-fold symmetry. The case of H^{\aff}_2 corresponding to planar point sets is discussed in detail. In contrast to the cut-and-project scheme we obtain by construction finite point sets, which grow with a model specific growth parameter.Comment: (27 pages, to appear in J. Phys. A

    Use of anticoagulants and antiplatelet agents in stable outpatients with coronary artery disease and atrial fibrillation. International CLARIFY registry

    Get PDF

    Comparative analysis of using natural and radiogenic lead as heat-transfer agent in fast reactors

    No full text
    Fast reactors with lead coolant have several advantages over analogues. Performance can be further improved by replacement of natural composition lead with radiogenic one. Thus, two main issues need to be addressed: induced radioactivity in coolant and efficient neutron multiplication factor in the core will be changed and need to be estimated. To address these issues analysis of the scheme of the nuclear transformations in the lead heat-transfer agent in the process of radiation was carried out. Induced radioactivity of radiogenic and natural lead has been studied. It is shown that replacement of lead affects multiplication factor in a certain way. Application of radiogenic lead can significantly affect reactor operation

    Chronic coronary syndromes without standard modifiable cardiovascular risk factors and outcomes: the CLARIFY registry

    No full text
    Background and Aims: It has been reported that patients without standard modifiable cardiovascular (CV) risk factors (SMuRFs—diabetes, dyslipidaemia, hypertension, and smoking) presenting with first myocardial infarction (MI), especially women, have a higher in-hospital mortality than patients with risk factors, and possibly a lower long-term risk provided they survive the post-infarct period. This study aims to explore the long-term outcomes of SMuRF-less patients with stable coronary artery disease (CAD). Methods: CLARIFY is an observational cohort of 32 703 outpatients with stable CAD enrolled between 2009 and 2010 in 45 countries. The baseline characteristics and clinical outcomes of patients with and without SMuRFs were compared. The primary outcome was a composite of 5-year CV death or non-fatal MI. Secondary outcomes were 5-year all-cause mortality and major adverse cardiovascular events (MACE—CV death, non-fatal MI, or non-fatal stroke). Results: Among 22 132 patients with complete risk factor and outcome information, 977 (4.4%) were SMuRF-less. Age, sex, and time since CAD diagnosis were similar across groups. SMuRF-less patients had a lower 5-year rate of CV death or non-fatal MI (5.43% [95% CI 4.08–7.19] vs. 7.68% [95% CI 7.30–8.08], P = 0.012), all-cause mortality, and MACE. Similar results were found after adjustments. Clinical event rates increased steadily with the number of SMuRFs. The benefit of SMuRF-less status was particularly pronounced in women. Conclusions: SMuRF-less patients with stable CAD have a substantial but significantly lower 5-year rate of CV death or non-fatal MI than patients with risk factors. The risk of CV outcomes increases steadily with the number of risk factors
    corecore